Despite optimal pharmacological treatment, many patients with chronic obstructive pulmonary disease remain very disabled. Bronchoscopic lung volume reduction involves the insertion of valves into the airways supplying emphysematous areas of lung with the intention of causing atelectasis and thus improving operating lung volumes. Bronchoscopic techniques are less hazardous than lung volume reduction surgery.
Introduction
Patients with advanced chronic obstructive pulmonary disease (COPD) continue to experience exertional breathlessness despite optimum medical therapy. In selected patients, lung volume reduction surgery (LVRS) has been shown to improve exercise capacity and quality of life [1] [2] [3] . LVRS, however, is not without risk. In particular, the National Emphysema Treatment Trial (NETT) found an excess mortality (16% at 30 days) in patients with the most severe disease. Even when highrisk patients were excluded, surgical volume reduction has been associated with significant morbidity and an early mortality rate of about 5% [1, 2] . For this reason, there is a need for safer alternatives. Bronchoscopic lung volume reduction (BLVR) has the potential to become such an alternative. A number of other bronchoscopically delivered techniques for the treatment of emphysema will also be touched on briefly in this review.
BLVR involves placing a device to obstruct the airway(s) leading to the most hyperinflated, emphysematous parts of the lung. The rationale for this approach is that endobronchial obstruction should cause these areas to collapse and thus, by reducing hyperinflation, alleviate symptoms without recourse to surgery. The technique was first performed using airway blockers [4, 5] and subsequently our group [6, 7 ] and others [8,9,10 ,11,12] have described early experience with the use of purpose designed endobronchially placed valves. A one-way valve is preferred as it allows air to exit the targeted lobe during expiration facilitating atelectasis. This permits secretions to drain and most importantly prevents the occurrence of potentially life-threatening acute local hyperinflation which can occur when the occluding device acts as a one-way valve the wrong way, with breaths stacking up behind the occlusion.
Available devices
Two valves are currently being evaluated in clinical trials. The Spiration Implantable Intrabronchial Valve (IBV valve; Spiration Inc., Redmond, Washington, USA) ( Fig. 1) is an umbrella-shaped device composed of a nitinol framework with struts covered by a flexible synthetic polymer cover. It is deployed from a catheter passed through the working channel of a bronchoscope. As the umbrella expands, the valve conforms to the shape of the bronchial wall with the umbrella permitting air to be exhaled but not inhaled. If the proximal central rod of the valve is grasped the umbrella collapses allowing the valve to be readily removed. This valve is the subject of a multicentre controlled trial but to date there are no published data in patients.
More evidence is available regarding the efficacy of the endobronchial valves (EBVs) produced by Emphasys Medical (Redwood City, California, USA). The first two devices were nitinol stents of a fixed size with a proximal silicone seal and an internal silicone duckbill valve that prevents air from entering the target lung but allows air and mucus to exit ( Fig. 2 ). Deployment of the first two versions of the valve required a wire exchange technique. A guidewire was passed into the selected orifice, the bronchoscope was removed and then the delivery catheter passed over the wire. The bronchoscope was reinserted so that the valve could be deployed under direct vision. Three sizes of valve were available.
The third and most recent version of the Emphasys EBV, the Zephyr valve, can now, like the Spiration IBV valve, be delivered from a catheter passed through the working channel of a bronchoscope ( Fig. 3 ). Two sizes of valve are available, 4 or 5.5 mm. A sizing device is passed down the bronchoscope first to enable the operator to select the appropriate size of valve for the airway that is being occluded. When deployed, the device expands to occlude the airway lumen. This device offers less resistance to expiratory flow, which in theory should improve emptying of the target lobe. The Zephyr valve is intended to be easy to remove if necessary.
Results of case series in humans using the Emphasys endobronchial valve
Snell et al. [8] studied 10 patients suitable for conventional LVRS, with upper lobe predominant heterogeneous emphysema. They targeted both upper lobes, aiming to occlude all segmental bronchi. There were no major complications. None of the patients, however, had significant atelectasis on computed tomography scanning at 30-day follow up. There was a significant decrease in upper lobe blood flow assessed by 99m Tc perfusion scanning and a significant improvement of gas transfer but without significant change in measures of airflow obstruction or lung volume. Of note, and contrary to other findings, subsequent bronchoscopic inspection revealed the valves to be venting in expiration in the majority of patients. It is probable that this was because of problems with the earliest valve design.
The other published case series have for the most part used the second-generation EBV, with some early 126 Obstructive, occupational and environmental diseases experience with the third-generation valve also reported. We described outcomes in 19 patients with heterogeneous emphysema, mean (SD) forced expiratory volume in 1 s (FEV 1 ) of 28.4% (11.9%) predicted, who had unilateral valve insertion [7 ] . Initially, we inserted these valves under general anaesthetic [13] . Subsequently, some procedures were carried out with sedation only and some of these were staged, with valves being inserted on two separate occasions, 1-2 weeks apart. The final four patients received the third-generation valve.
At 4 weeks after the procedure, mean functional residual capacity had fallen significantly from 7.1 (1.5) to 6.6 (1.7) l and diffusing capacity risen from 3.3 (1.1) to 3.7 (1.2) mmol min À1 kPa À1 . Cycle endurance time at 80% of peak workload pre-procedure increased dramatically from 227 (129) to 315 (195) s. This was associated with an improvement in dynamic hyperinflation, with a reduction in end-expiratory lung volume at peak exercise from 7.6 (1.6) to 7.2 (1.7) l. Using stepwise logistic regression analysis, a model containing changes in transfer factor and resting inspiratory capacity explained 81% of the variation in change in exercise time. The same variables were retained if the five patients with radiological atelectasis were excluded from analysis, although the magnitude of improvement was less. In a subgroup of patients in whom invasive measurements were performed, improvement in exercise capacity was associated with a reduction in lung compliance and work of breathing assessed as isotime oesophageal pressure-time product. Two patients developed pneumothoraces, one requiring intercostal tube drainage.
Yim et al. [9] have described the results of predominantly unilateral valve insertion in 21 patients, targeting the most emphysematous segments using the second-generation valve. At 90 days follow up they observed significant increases in FEV 1 and vital capacity as well as 6 min walk distance, Medical Research Council (MRC) dyspnoea score and quality of life. Only four patients had over 75% collapse in the target lobe [9] .
Venuta et al. [11] performed unilateral BLVR in 11 patients and staged bilateral procedures in two using second-generation valves. A severe group of patients were chosen, all requiring supplemental oxygen at rest prior to the procedure. Six complications occurred in three patients: two bilateral and one contralateral pneumothorax, one pneumonia, and two episodes of bronchospasm. Functional results at 1 and 3 months showed a significant improvement in FEV 1 , residual volume, and 6 min walk test; 43% of the patients no longer required supplemental oxygen. The posttreatment MRC median dyspnoea score at 1 and 3 months was 2. Bronchoscopic follow up at 1 and 3 months showed that the valves were correctly in place with no granulation. The rate of radiological atelectasis is not reported.
de Oliviera [12] described the results of EBV insertion in 19 patients (eight bilateral) with heterogeneous emphysema, 12 receiving third-generation valves. A statistically significant improvement in 6 min walk distance was observed at 1 month but no significant difference in lung function parameters. There was transient radiological atelectasis in two patients but this did not persist. Two developed a pneumothorax, one of which required the removal of the valves, and in another patient the valves were removed because of respiratory dysfunction and bronchial hypersecretion. This group reported that granulation tissue occurred commonly with the secondgeneration valve but only infrequently (one out of 10 at 1 year follow up) in the third-generation valve.
The largest series to date describes 98 patients with COPD treated with the second-generation EBV in multiple centres. An average of four valves per patient were inserted. Exercise tolerance and lung function improved significantly with an acceptable safety profile at 90 days [10 ] . The incidence of radiological atelectasis is unfortunately not reported. Three patients developed pneumothoraces requiring surgical intervention and four prolonged air leaks occurred. Pneumothoraces occurred exclusively in patients in which an entire lobe was targeted. One patient died having developed pneumonia in a targeted part of the lung. Patients with the most gas trapping at baseline (residual volume over 225% predicted) also tended to have the greatest improvement. There was a trend towards greater improvement in patients treated unilaterally rather than bilaterally and in those who had treatment targeting an entire lobe. This finding needs to be treated with caution as these were not a-priori categories; targeting strategy and patient selection criteria varied between sites and the two factors were not independent, because targeting was more likely to be lobar when a unilateral approach was adopted. It may also be that lobar collapse is facilitated if there is some potential for expansion contralaterally
Mechanisms for success or failure
Although atelectasis of emphysematous lung is the intended consequence of BLVR, pilot work has shown both that lobar collapse occurs relatively infrequently and that it is not necessary for clinically apparent benefit, suggesting that other physiological mechanisms must operate. It should be noted that this assessment can be technically difficult because the emphysematous destruction present makes accurate location of landmarks such as fissures problematic. The presence of collateral ventilation was first confirmed by Van Allen et al. [14] , who observed that significant gas exchange and ventilation could occur distal to a complete bronchial obstruction, implying that there must be connections between obstructed and unobstructed lung. The process of alveolar destruction that occurs in emphysema leads to a destruction of normal lung architecture, with incomplete interlobar fissures more common in emphysematous than in normal lungs [15] . Significant collateral ventilation through alveolar-lobar pores has also been observed at postmortem in these patients [16] . Recently, interlobar collaterals have been demonstrated in 15 out of 23 explanted lungs from patients with severe emphysema undergoing lung transplantation [17 ] . Importantly, the presence of collaterals was associated with a homogeneous distribution of emphysema on computed tomography scan and this suggests that patients with heterogeneous disease may benefit more from valve treatments as is the case with LVRS. Intuitively, it seems likely that collateral ventilation will occur within a lobe more frequently than between lobes, which may explain the trend towards greater benefit when a lobar approach is taken [10 ] .
A key element in the ventilatory limitation of exercise in COPD is the development of dynamic hyperinflation, where expiratory flow limitation leads to a progressive increase in end expiratory lung volume during exercise and consequently restricts the tidal volume that can be achieved (reviewed in Calverley et al. [18 ] ). We have demonstrated that BLVR is associated with improved exercise capacity in the context of reductions in dynamic hyperinflation. This also occurred (though to a lesser extent) in patients who did not have radiological atelectasis. In patients with only a modest amount of collateral ventilation, valve insertion may still direct airflow into less affected areas of lung, reducing dynamic hyperinflation during exercise.
Gas transfer improves significantly following valve insertion, and we found that change in this parameter was highly correlated with improvement in exercise capacity. BLVR may allow the recruitment of previously 'compressed' alveolar units. BLVR may improve cardiac function by reducing intrathoracic pressure swings (as observed in our series), thus increasing pulmonary capillary volume, as has been observed following LVRS [19] . If the targeted area of lung is the most emphysematous, it would be expected to have the slowest time constants and might therefore have been contaminating the 'alveolar' part of the sample during the expiration when gas transfer was measured prior to the procedure. Excluding this area from ventilation would reduce inhomogeneity of gas mixing. This mechanism may more properly be thought of as a measurement error, although it does reflect emphysematous pathophysiology. Interestingly, improvements in gas transfer appear to be a consistent feature of BLVR whereas following LVRS, perhaps because the technique inevitably requires the removal of some relatively normal lung tissue, it has not improved in a number of studies [1, 20] , although this has not been a universal finding [21, 22] .
LVRS is known to improve inspiratory muscle function [22] and we found that the reduction in static lung volumes we observed following BLVR was also associated with an improvement in diaphragm function, assessed as twitch transdiaphragmatic pressure in response to anterolateral magnetic phrenic nerve stimulation [7 ] .
Collapse of a targeted lobe following BLVR may also be hindered by pleural adhesions and these may also, if collapse does occur, cause parenchymal tears and a risk of pneumothorax. Pneumothorax may also occur if the rapid expansion of a bulla in an adjacent lobe causes it to rupture, as observed in one case [10 ] in which a right lower lobe bulla had ruptured following targeting of the right upper lobe which had led to lobar atelectasis. Some of the pneumothoraces observed are likely to have occurred ex vacuo rather than because of an air leak.
In our series, improvement in exercise capacity was greatest in those with the highest respiratory rates during their baseline exercise test. We also observed that patients whose exercise was wholly or partly limited by leg discomfort were less likely to benefit, which is consistent with the concept that interventions to improve exercise capacity by improving ventilation may not be effective if exercise is limited by leg fatigue [23, 24] .
Use of endobronchial valves to close persistent air leaks
A number of case reports have been published describing the successful treatment of persistent air leaks using EBVs in a range of contexts [25] [26] [27] [28] [29] [30] . Examples of these include following lung resection for aspergilloma [28] , after feeding tube malpositioning [26] , following LVRS [30] , in disseminated malignancy [27] and in empyema [29] . Theoretically it may be appropriate to remove the valve or valves subsequently, assuming that the hole in the pleura has healed, but since the valves appear to be well tolerated none of the groups have reported going on to do this.
Other bronchoscopic approaches to treat emphysema
The airway bypass technique involves inserting stents from cartilaginous airways into emphysematous lung, providing additional pathways for expiration. This should reduce gas trapping and by producing a low resistance pathway should have more effect in the presence of collateral ventilation rather than being hindered by it. Broncus Technologies Inc. (Mountain View, California) have developed a system in which stents are inserted under Doppler ultrasound guidance to ensure that blood vessels are not punctured. Initial work [31] has shown this technique to be feasible, with studies in the lungs of patients with emphysema at surgery prior either to lobectomy or transplantation [31] . Pilot data are accumulating in patients, though none have yet been published. A multicentre randomized controlled trial is due to start by the end of 2006.
Another approach has been to find tissue engineering approaches that will produce lung volume reduction by causing scarring in target areas of the lung [32, 33] . Only animal data are available at present and it remains unclear whether it will be possible to apply this technique to humans. It is possible that these substances could be used in conjunction with endobronchial devices in order to facilitate atelectasis. An obvious technical issue, given the presence of collateral pathways, is ensuring that the substance used is confined to the target area and does not spill into healthier areas of the lung. Short-acting agents that are suspended in a foam or biogel may address this.
Conclusion
Studies of BLVR that have so far been published have all been uncontrolled and unblinded, and as such, are open to potential bias from enthusiastic investigators and optimistic patients. They do provide encouraging, preliminary data about the safety and efficacy of these devices. The results of a multicentre randomized trial of BLVR using the EBV, the Endobronchial Valve for Emphysema Palliation Trial (VENT), are anticipated in 2007. Other trials are also underway which together will hopefully provide a definite indication of the future for these new technologies. It may prove to be the case that valve insertion will be the appropriate therapy when there is heterogeneous disease and a target lobe can be identified. In homogeneous disease, with intralobar collateral ventilation being more likely, the airway bypass approach may prove to be preferable. Alternatively, it may be that rather than relying on these categories, direct measurement of collateral ventilation [34] using mass spectroscopy will be a better approach.
